Stock-Based Compensation (Tables)

12 Months Ended

Apr. 30, 2025

Share-Based Payment Arrangement [Abstract]

The following table contains a summary of the Company's RSU activity for the fiscal years ended April 30, 2025, 2024, and 2023:


	PERFORMANCE-BASED RSUs	SERVICE-BASED RSUs	TOTAL RSUs	WEIGHTED AVERAGE GRANT DATE FAIR VALUE
Issued and outstanding, April 30, 2022	154,610	147,234	301,844	$69.10

Granted	119,772	82,848	202,620	$51.77
Cancelled due to non-achievement of performance goals	(38,454)	—	(38,454)	$73.85
Settled in common stock	(19,478)	(49,916)	(69,394)	$63.12
Forfeited	(16,620)	(9,986)	(26,606)	$63.15
Issued and outstanding, April 30, 2023	199,830	170,180	370,010	$61.77

Granted	155,062	79,778	234,840	$63.41
Cancelled due to non-achievement of performance goals	(9,949)	—	(9,949)	$63.83
Settled in common stock	(45,109)	(68,034)	(113,143)	$65.02
Forfeited	(14,939)	(8,400)	(23,339)	$66.52
Issued and outstanding, April 30, 2024	284,895	173,524	458,419	$61.85

Granted	98,391	60,159	158,550	$86.74
Cancelled due to non-achievement of performance goals	(1,555)	—	(1,555)	$85.59
Settled in common stock	(33,488)	(75,234)	(108,722)	$73.93
Forfeited	(26,792)	(10,363)	(37,155)	$65.49
Issued and outstanding, April 30, 2025	321,451	148,086	469,537	$66.71

Stock-Based Compensation Expense Allocated

For the fiscal years ended April 30, 2025, 2024, and 2023, stock-based compensation expense was allocated as follows:


	FISCAL YEARS ENDED APRIL 30,
(in thousands)	2025		2024		2023
Cost of sales and distribution	$	1,917	$	2,377	$	2,154
Selling and marketing expenses	943		2,364		1,941
General and administrative expenses	5,129		5,941		3,301
Stock-based compensation expense, before income taxes	$	7,989	$	10,682	$	7,396

Schedule Of Stock Option Activity

The following table presents a summary of the Company’s stock option activity for the fiscal years ended April 30, 2025 and 2024 (remaining contractual term in years and exercise prices are weighted-averages):


	NUMBER OF OPTIONS	WEIGHTED AVERAGE REMAINING CONTRACTUAL TERM	WEIGHTED AVERAGE EXERCISE PRICE		AGGREGATE INTRINSIC VALUE (in thousands)
Outstanding at April 30, 2023	—	0	$	—	$	—

Granted	92,340	9.4	77.19		$	1,375
Exercised	—	0	—		$	—
Cancelled or expired	(10,260)	0	77.19		$	153
Outstanding at April 30, 2024	82,080	9.4	$	77.19	$	1,222

Granted	—	0.0	—		$	—
Exercised	—	0	—		$	—
Cancelled or expired	(10,260)	8.4	77.19		$	—
Outstanding at April 30, 2025	71,820	8.4	$	77.19	$	—

Vested and expected to vest in the future at April 30, 2025	71,820	8.4	$	77.19	$	—
Exercisable at April 30, 2025	—	0	$	—	$	—